ysis inhibition by tranexamic acid in vitro and in vivo
- Conditions
- test for point-of-care diagnostics (visco-elastic methods)D68Other coagulation defects
- Registration Number
- DRKS00015269
- Lead Sponsor
- Klinik für Anästhesiologie, Klinikum der Universität München, LMU München
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 67
Inclusion Criteria
Age > 18 years
No coagulation disorder
No anticoagulatory medication
Exclusion Criteria
Age < 18 Years
Anticoagulants
Coaguation disorder
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method in-vitro: Change of lysis time (LT) in viscoelastic test. Measurement for every concentration.<br>in-vivo: Change of lysis time (LT) in viscoelastic test. Measurement after every withdraw of blood.
- Secondary Outcome Measures
Name Time Method in-vivo: blood loss at end of surgery